- Quarterly investor conference call and webcast scheduled for Tuesday, February 27 at 8:30 a.m. ET
WESTLAKE VILLAGE, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report its fourth quarter and full year financial results and provide a business update on Tuesday, February 27, 2024. Arcutis management will host a conference call and webcast that day at 8:30 a.m. ET.
A live webcast of the call and the presentation material will be available on the "Events" section of the Company's investor website. An archived replay of the webcast will be available on the Arcutis investor website following the conference call.
About Arcutis
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is a commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with ...